NIAID Banner Logo Image

Opportunistic Infections Citation List:

January 6 - January 19, 2012

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Trivalent Ultrashort Lipopeptides are Potent Ph Dependent Antifungal Agents. Arnusch, C.J., H.B. Albada, M. van Vaardegem, R.M. Liskamp, H.G. Sahl, Y. Shadkchan, N. Osherov, and Y. Shai. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22243686].

[PubMed]. OI_0106-011912.

2. Susceptibilities of Candida albicans Mouth Isolates to Antifungal Agents, Essentials Oils and Mouth Rinses. Carvalhinho, S., A.M. Costa, A.C. Coelho, E. Martins, and A. Sampaio. Mycopathologia, 2012. [Epub ahead of print]; PMID[22246961].

[PubMed]. OI_0106-011912.

3. Effect of Ph on in Vitro Susceptibility of Candida glabrata and Candida albicans to Eleven Antifungal Agents - Implications for Clinical Use. Danby, C.S., D. Boikov, R. Rautemaa, and J.D. Sobel. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22232293].

[PubMed]. OI_0106-011912.

4. Chemical Compositions of the Essential Oils of Aerial Parts of Chamaemelum Mixtum (L.) Alloni. Darriet, F., M. Bendahou, J. Costa, and A. Muselli. Journal of Agricultural and Food Chemistry, 2012. [Epub ahead of print]; PMID[22225420].

[PubMed]. OI_0106-011912.

5. Cranberry Proanthocyanidins Inhibit the Adherence Properties of Candida albicans and Cytokine Secretion by Oral Epithelial Cells. Feldman, M., S. Tanabe, A. Howell, and D. Grenier. Bmc Complementary and Alternative Medicine, 2012. 12(1): p. 6; PMID[22248145].

[PubMed]. OI_0106-011912.

6. Novel Copper-Based Therapeutic Agent for Anti-Inflammatory: Synthesis, Characterization, and Biochemical Activities of Copper(Ii) Complexes of Hydroxyflavone Schiff Bases. Joseph, J. and K. Nagashri. Applied Biochemistry and Biotechnology, 2012. [Epub ahead of print]; PMID[22238015].[PubMed]. OI_0106-011912.

7. Chemical Composition and Antifungal Activity of Essential Oils and Supercritical Co(2) Extracts of Apium nodiflorum (L.) lag. Maxia, A., D. Falconieri, A. Piras, S. Porcedda, B. Marongiu, M.A. Frau, M.J. Goncalves, C. Cabral, C. Cavaleiro, and L. Salgueiro. Mycopathologia, 2012. [Epub ahead of print]; PMID[22237925].

[PubMed]. OI_0106-011912.

8. In Vitro Antimicrobial Synergism within Plant Extract Combinations from Three South African Medicinal Bulbs. Ncube, B., J.F. Finnie, and J. Van Staden. Journal of Ethnopharmacology, 2012. 139(1): p. 81-89; PMID[22075455].

[PubMed]. OI_0106-011912.

9. Antimicrobial Activity of Peptides Derived from Human Ss-Amyloid Precursor Protein. Papareddy, P., M. Morgelin, B. Walse, A. Schmidtchen, and M. Malmsten. Journal of Peptide Science: An Official Publication of the European Peptide Society, 2012. [Epub ahead of print]; PMID[22249992].

[PubMed]. OI_0106-011912.

10. Calix[4]arene Based 1,3,4-Oxadiazole and Thiadiazole Derivatives: Design, Synthesis, and Biological Evaluation. Patel, M.B., N.R. Modi, J.P. Raval, and S.K. Menon. Organic & Biomolecular Chemistry, 2012. [Epub ahead of print]; PMID[22246169].

[PubMed]. OI_0106-011912.

11. Species and Susceptibility Distribution of 1062 Clinical Yeast Isolates to Azoles, Echinocandins, Flucytosine and Amphotericin B from a Multi-Centre Study. Schmalreck, A.F., B. Willinger, G. Haase, G. Blum, C. Lass-Florl, W. Fegeler, and K. Becker. Mycoses, 2012. [Epub ahead of print]; PMID[22233267].

[PubMed]. OI_0106-011912.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

12. Discovery of Novel Antitubercular 1,5-Dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-Yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one Analogues. Ahsan, M.J., J.G. Samy, C.B. Jain, K.R. Dutt, H. Khalilullah, and M.S. Nomani. Bioorganic & Medicinal Chemistry Letters, 2012. 22(2): p. 969-972; PMID[22197387].

[PubMed]. OI_0106-011912.

13. Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-based Drug Design to Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors. Flipo, M., M. Desroses, N. Lecat-Guillet, B. Villemagne, N. Blondiaux, F. Leroux, C. Piveteau, V. Mathys, M.P. Flament, J. Siepmann, V. Villeret, A. Wohlkonig, R. Wintjens, S.H. Soror, T. Christophe, H.K. Jeon, C. Locht, P. Brodin, B. Deprez, A.R. Baulard, and N. Willand. Journal of Medicinal Chemistry, 2012. 55(1): p. 68-83; PMID[22098589].

[PubMed]. OI_0106-011912.

14. Investigating the Spectrum of Biological Activity of Substituted Quinoline-2-carboxamides and Their Isosteres. Gonec, T., P. Bobal, J. Sujan, M. Pesko, J. Guo, K. Kralova, L. Pavlacka, L. Vesely, E. Kreckova, J. Kos, A. Coffey, P. Kollar, A. Imramovsky, L. Placek, and J. Jampilek. Molecules (Basel, Switzerland), 2012. 17(1): p. 613-644; PMID[22233564].

[PubMed]. OI_0106-011912.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

15. In Vitro and in Silico Studies of Polycondensed Diazine Systems as Anti-parasitic Agents. Almerico, A.M., M. Tutone, A. Guarcello, and A. Lauria. Bioorganic & Medicinal Chemistry Letters, 2012. 22(2): p. 1000-4; PMID[22197138].

[PubMed]. OI_0106-011912.

16. Synthesis of 9-Phosphonoalkyl and 9-Phosphonoalkoxyalkyl Purines: Evaluation of Their Ability to Act as Inhibitors of Plasmodium falciparum, Plasmodium vivax and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferases. Cesnek, M., D. Hockova, A. Holy, M. Dracinsky, O. Baszczynski, J. Jersey, D.T. Keough, and L.W. Guddat. Bioorganic & Medicinal Chemistry, 2012. 20(2): p. 1076-1089; PMID[22178188].

[PubMed]. OI_0106-011912.

17. Ruthenium(Ii) arene Complexes with Chelating Chloroquine Analogue Ligands: Synthesis, Characterization and in Vitro Antimalarial Activity. Glans, L., A. Ehnbom, C. de Kock, A. Martinez, J. Estrada, P.J. Smith, M. Haukka, R.A. Sanchez-Delgado, and E. Nordlander. Dalton Transactions (Cambridge, England : 2003), 2012. [Epub ahead of print]; PMID[22249579].

[PubMed]. OI_0106-011912.

18. Design and Synthesis of Small Molecular Dual Inhibitor of Falcipain-2 and Dihydrofolate Reductase as Antimalarial Agent. Huang, H., W. Lu, X. Li, X. Cong, H. Ma, X. Liu, Y. Zhang, P. Che, R. Ma, H. Li, X. Shen, H. Jiang, J. Huang, and J. Zhu. Bioorganic & Medicinal Chemistry Letters, 2012. 22(2): p. 958-962; PMID[22192590].

[PubMed]. OI_0106-011912.

19. Ethnobotanical Study of Antimalarial Plants in Shinile District, Somali Region, Ethiopia, and in Vivo Evaluation of Selected Ones against Plasmodium berghei. Mesfin, A., M. Giday, A. Animut, and T. Teklehaymanot. Journal of Ethnopharmacology, 2012. 139(1): p. 221-227; PMID[22101085].

[PubMed]. OI_0106-011912.

20. New Antimalarial Indolone-N-oxides, Generating Radical Species, Destabilize the Host Cell Membrane at Early Stages of Plasmodium falciparum Growth: Role of Band 3 Tyrosine Phosphorylation. Pantaleo, A., E. Ferru, R. Vono, G. Giribaldi, O. Lobina, F. Nepveu, H. Ibrahim, J.P. Nallet, F. Carta, F. Mannu, P. Pippia, E. Campanella, P.S. Low, and F. Turrini. Free Radical Biology & Medicine, 2012. 52(2): p. 527-536; PMID[22142474].

[PubMed]. OI_0106-011912.

21. New Benzimidazole Derivatives as Antiplasmodial Agents and Plasmepsin Inhibitors: Synthesis and Analysis of Structure-Activity Relationships. Saify, Z.S., M.K. Azim, W. Ahmad, M. Nisa, D.E. Goldberg, S.A. Hussain, S. Akhtar, A. Akram, A. Arayne, A. Oksman, and I.A. Khan. Bioorganic & Medicinal Chemistry Letters, 2012. 22(2): p. 1282-1286; PMID[22204908].

[PubMed]. OI_0106-011912.

22. Antiplasmodial Activity of Steroidal Chalcones: Evaluation of Their Effect on Hemozoin Synthesis and the New Permeation Pathway of Plasmodium falciparum-Infected Erythrocyte Membrane. Sisodia, B.S., A.S. Negi, M.P. Darokar, U.N. Dwivedi, and S.P. Khanuja. Chemical Biology & Drug Design, 2012. [Epub ahead of print]; PMID[22248242].

[PubMed]. OI_0106-011912.

23. Synthesis, Biological Evaluation and Mechanistic Studies of Totarol amino alcohol Derivatives as Potential Antimalarial Agents. Tacon, C., E.M. Guantai, P.J. Smith, and K. Chibale. Bioorganic & Medicinal Chemistry, 2012. 20(2): p. 893-902; PMID[22196513].

[PubMed]. OI_0106-011912.

24. Febrifugine Analogue Compounds: Synthesis and Antimalarial Evaluation. Zhu, S., G. Chandrashekar, L. Meng, K. Robinson, and D. Chatterji. Bioorganic & Medicinal Chemistry, 2012. 20(2): p. 927-932; PMID[22182577].

[PubMed]. OI_0106-011912.

Citations from the ISI Web of Knowledge Listings for O.I.

25. Chemical Constituents of the Methanolic Extract of Leaves of Leiothrix spiralis ruhland and Their Antimicrobial Activity. Araujo, M.G.D., F. Hilario, L.G. Nogueira, W. Vilegas, L.C. dos Santos, and T.M. Bauab. Molecules, 2011. 16(12): p. 10479-10490; ISI[000298411200051].

[WOS]. OI_0106-011912.

26. Synthesis, Characterization, Anti-inflammatory and in Vitro Antimicrobial Activity of Some Novel Alkyl/Aryl substituted tertiary alcohols. Baseer, M., F.L. Ansari, Z. Ashraf, and R. SaeedulHaq. Molecules, 2011. 16(12): p. 10337-10346; ISI[000298411200040].

[WOS]. OI_0106-011912.

27. Microwave-assisted Synthesis of New N(1),N(4)-Substituted thiosemicarbazones. dos Reis, C.M., D.S. Pereira, R.D. Paiva, L.F. Kneipp, and A. Echevarria. Molecules, 2011. 16(12): p. 10668-10684; ISI[000298411200063].

[WOS]. OI_0106-011912.

28. Oxathiazole-2-one Derivative of Bortezomib: Synthesis, Stability and Proteasome Inhibition Activity. Gryder, B.E., W. Guerrant, C.H. Chen, and A.K. Oyelere. Medchemcomm, 2011. 2(11): p. 1083-1086; ISI[000297960100008].

[WOS]. OI_0106-011912.

29. In Vitro Antibacterial and Antifungal Activity of Iraqi propolis. Hendi, N.K.K., H.S. Naher, and A.H. Al-Charrakh. Journal of Medicinal Plants Research, 2011. 5(20): p. 5058-5066; ISI[000297457400013].

[WOS]. OI_0106-011912.

30. Candidacidal Action of Cf66i, an Antifungal Compound Produced by Burkholderia cepacia. Li, X., H.Y. Yu, and C.S. Quan. Tropical Journal of Pharmaceutical Research, 2011. 10(5): p. 577-584; ISI[000298174900006].

[WOS]. OI_0106-011912.

31. Biological Properties of the Cotinus coggygria Methanol Extract. Matic, S., S. Stanic, S. Solujic, T. Milosevic, and N. Niciforovic. Periodicum Biologorum, 2011. 113(1): p. 87-92; ISI[000298216000012].

[WOS]. OI_0106-011912.

32. Evaluation of the Antifungal Activity of the Iranian Thyme Essential Oils on the Postharvest Pathogens of Strawberry Fruits. Nabigol, A. and H. Morshedi. African Journal of Biotechnology, 2011. 10(48): p. 9864-9869; ISI[000298385000020].

[WOS]. OI_0106-011912.

33. Antimicrobial Potential of the Selected Plant Species against Some Infectious Microbes Used. Naz, R., A. Bano, H. Yasmin, Samiullah, and U. Farooq. Journal of Medicinal Plants Research, 2011. 5(21): p. 5247-5253; ISI[000297458400007].

[WOS]. OI_0106-011912.

34. Antifungal Activity of the Essential Oil of Iranian Medicinal Plants. Pirbalouti, A.G., B. Hamedi, R. Abdizadeh, and F. Malekpoor. Journal of Medicinal Plants Research, 2011. 5(20): p. 5089-5093; ISI[000297457400018].

[WOS]. OI_0106-011912.

35. Synthesis and in-Vitro Activity of Some New Class of Thiazolidinone and Their Arylidene Derivatives. Seelam, N. and S.P. Shrivastava. Bulletin of the Korean Chemical Society, 2011. 32(11): p. 3996-4000; ISI[000297398800028].

[WOS]. OI_0106-011912.

36. Nutraceutical Potential and Bioassay of Apium graveolens l. Grown in Khyber Pakhtunkhwa-Pakistan. Shad, A.A., H.U. Shah, J. Bakht, M.I. Choudhary, and J. Ullah. Journal of Medicinal Plants Research, 2011. 5(20): p. 5160-5166; ISI[000297457400031].

[WOS]. OI_0106-011912.

37. Chemical Composition, Antimicrobial Activity, Proximate Analysis and Mineral Content of the Seed of Detarium senegalense Jf Gmelin. Sowemimo, A.A., C. Pendota, B. Okoh, T. Omotosho, N. Idika, A.A. Adekunle, and A.J. Afolayan. African Journal of Biotechnology, 2011. 10(48): p. 9875-9879; ISI[000298385000022].

[WOS]. OI_0106-011912.

38. Toxicity Effect of Cr (Vi) and Zn (Ii) on Growth of Filamentous Fungi Aspergillus niger Isolated from Industrial Effluent. Vale, M.D., K.D. Abreu, S.T. Gouveia, R.C. Leitao, and S.T. Santaella. Engenharia Sanitaria E Ambiental, 2011. 16(3): p. 237-244; ISI[000297562200005].

[WOS]. OI_0106-011912.

39. Synthesis and Inhibitory Activity of Thymidine Analogues Targeting Mycobacterium tuberculosis Thymidine monophosphate kinase. Van Poecke, S., H. Munier-Lehmann, O. Helynck, M. Froeyen, and S. Van Calenbergh. Bioorganic & Medicinal Chemistry, 2011. 19(24): p. 7603-7611; ISI[000297860100033].

[WOS]. OI_0106-011912.

40. Direct in Vivo Interaction of the Antibiotic Primycin with the Plasma Membrane of Candida albicans: An EPR Study. Virag, E., J. Belagyi, Z. Gazdag, C. Vagvolgyi, and M. Pesti. Biochimica Et Biophysica Acta-Biomembranes, 2012. 1818(1): p. 42-48; ISI[000298461100006].

[WOS]. OI_0106-011912.

41. Discovery of Highly Potent Antifungal Triazoles by Structure-based Lead Fusion. Wang, W.Y., S.Z. Wang, G.Q. Dong, Y. Liu, Z.Z. Guo, Z.Y. Miao, J.Z. Yao, W.N. Zhang, and C.Q. Sheng. Medchemcomm, 2011. 2(11): p. 1066-1072; ISI[000297960100005].

[WOS]. OI_0106-011912.

42. Preparation, Characterization and Antimicrobial Activity of 6-Amino-6-deoxychitosan. Yang, J.H., J. Cai, Y. Hu, D.L. Li, and Y.M. Du. Carbohydrate Polymers, 2012. 87(1): p. 202-209; ISI[000297389000027].

[WOS]. OI_0106-011912.

43. Bisbibenzyls, a New Type of Antifungal Agent, Inhibit Morphogenesis Switch and Biofilm Formation through Upregulation of DPP3 in Candida albicans. Zhang, L., W.Q. Chang, B. Sun, M. Groh, A. Speicher, and H.X. Lou. Plos One, 2011. 6(12); ISI[000298366600052].

[WOS]. OI_0106-011912.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022